You are using an older browser version. Please use a supported version for the best MSN experience.

Vaccine hopes rise as Oxford jab prompts immune response among old as well as young adults

The COVID-19 vaccine being developed by AstraZeneca and the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among the elderly, the UK drugmaker said on Monday. Francis Maguire reports.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon